Frontline Therapy in Multiple Myeloma: Fast Start for a Long Game

The Lancet Haematology - United Kingdom
doi 10.1016/s2352-3026(19)30199-1
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Elsevier BV

Related search

BiTE Therapy Active in Multiple Myeloma

Cancer Discovery
Oncology
2019English

Lipid Raft-Targeted Therapy in Multiple Myeloma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2010English

Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

International Journal of Hematology
Hematology
2020English

Improvement in Long-Term Outcomes With Successive Total Therapy Trials for Multiple Myeloma: Are Patients Now Being Cured?

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2012English

Pulmonary Embolism Developing During Thalidomide Therapy for Multiple Myeloma in a Hemodialysis Patient

Nihon Toseki Igakkai Zasshi
2011English

A Dose Increased Once-Weekly Bortezomib-Based Combination Therapy for Multiple Myeloma

Oncotarget
Oncology
2016English

Bortezomib-Based Consolidation or Maintenance Therapy for Multiple Myeloma: A Meta-Analysis

Blood Cancer Journal
OncologyHematology
2020English

Combination Therapy for Multiple Myeloma: How Far Have We Come?

Journal of Developing Drugs
2012English

Induction Therapy for Multiple Myeloma: More Is Not Necessarily Better!

British Journal of Haematology
Hematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy